Skip to Main Content

Paper Details

Continued androgen signalling inhibition improves cabazitaxel efficacy in prostate cancer.
EBioMedicine
5
2021
Author NameAffiliation
Pim J FrenchCancer Treatment Screening Facility Erasmus University MC, the Netherlands Department of Neurology Erasmus University MC
Harmen J G van de WerkenDepartment of Urology Erasmus University MC, the Netherlands Cancer Computational Biology Center Erasmus MC Cancer Institute, University Medical Center
Ronald de WitDepartment of Medical Oncology Erasmus MC Cancer Institute
Martijn P LolkemaDepartment of Medical Oncology Erasmus MC Cancer Institute
  • 1 - 4

Datasets